Old Web
English
Sign In
Acemap
>
Paper
>
1378OARCTIC: Durvalumab + tremelimumab and durvalumab monotherapy vs SoC in ≥ 3L advanced NSCLC treatment
1378OARCTIC: Durvalumab + tremelimumab and durvalumab monotherapy vs SoC in ≥ 3L advanced NSCLC treatment
2018
Dariusz M. Kowalski
N. Reinmuth
S. Orlov
J. R. Fischer
S. Sugawara
S Mandziuk
D M Medine
Silvia Novello
Y Takeda
R A Soo
K. Park
Michael J. McCleod
Sarayut Lucien Geater
M Powell
R May
Paul Stockman
David Planchard
Keywords:
General surgery
Oncology
Durvalumab
Medicine
Tremelimumab
Internal medicine
Arctic
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
17
Citations
NaN
KQI
[]